Tag: Factor Xa
European Medicines Agency issues positive opinion for rivaroxaban
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion on a label update...
Andexanet alfa study shows rapid and substantial anti-Factor Xa activity reversion
Portola Pharmaceuticals has announced interim results from the ongoing phase3b/4 ANNEXA-4 study of andexanet alfa (AndexXa), a Factor Xa inhibitor antidote.
In this study of...